FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1017-1018 March 29, 2001 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: In the November 30 issue of the Journal, four articles addressed financial conflicts of interest for academic investigators working with industry. The articles by Lo et al.¹ and McCrary et al.² provide important data and insight into the extent of the problem. The editorial by Drazen and Koski³ highlights the central issue that arises when an investigator has an equity stake in a sponsoring company while conducting a clinical trial. Martin and Kasper,⁴ representing Harvard Medical School, present their position on conflicts of interest and assert "we chose to retain our current strict standards."

The assertion by . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.